Advice

Following an abbreviated submission

desmopressin oral lyophilisate (DDAVP Melt®) is accepted for use in NHS Scotland for the treatment of vasopressin-sensitive cranial diabetes insipidus and in the treatment of post-hypophysectomy polyuria/polydipsia.

In patients for whom desmopressin is an appropriate choice of therapy, it offers a sublingual formulation at an equivalent cost to a clinically equivalent dose in a solid oral dose formulation.

Download detailed advice26KB (PDF)

Download

Medicine details

Medicine name:
desmopressin 60, 120 and 240 micrograms oral lyophilisate (DDAVP Melt)
SMC ID:
358/07
Indication:
Vasopressin-sensitive cranial diabetes insipidus/post-hypophysectomy polyuria/polydipsia
Pharmaceutical company
Ferring Pharmaceuticals Ltd
BNF chapter
Endocrine system
Submission type
Abbreviated
Status
Accepted
Date advice published
07 May 2007